Organon, a global healthcare company with a deep expertise in biosimilars, today announced that it has acquired from Biogen Inc.  regulatory and commercial rights in the U.S. for TOFIDENCE, a biosimilar to ACTEMRA®, for intravenous infusion. TOFIDENCE, the first…

Mallinckrodt Pharmaceuticals and Endo have agreed to merge in a $6.7bn deal, combining two pharmaceutical companies that recently emerged from bankruptcy proceedings tied to opioid litigation. The merger will create a “larger, more diversified entity”, with Mallinckrodt shareholders holding a…